$CYTK Recent News This tiny biotech company ta
Post# of 88933
Posted On: 01/19/2015 10:23:12 AM
$CYTK Recent News
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
Cytokinetics plunges 60% after Lou Gehrig's disease drug fails test 9:26 a.m. April 25, 2014 - Russ Britt
Cytokinetics's massive stock plunge may be premature, analyst says 5:18 p.m. Sept. 3, 2013 - Russ Britt
Cytokinetics shares plummet after heart drug fails to meet primary goal 9:56 a.m. Sept. 3, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 6:57 a.m. Aug. 14, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:00 a.m. July 24, 2013 - Shawn Langlois
Cytokinetics rallies on study publication 11:31 a.m. Sept. 27, 2011 - Val Brickates Kennedy
Cytokinetics sinks 18% in early trading 10:37 a.m. Aug. 8, 2011 - Val Brickates Kennedy
Drug indexes hug the flat line 10:57 a.m. Dec. 13, 2010 - Val Brickates Kennedy
Drug indexes sluggish; Cytokinetics plunges 10:07 a.m. Dec. 13, 2010 - Val Brickates Kennedy
Cytokinetics shares up 5% 9:34 a.m. Dec. 7, 2010 - Nick Godt
Cytokinetics to begin Phase II testing of ALS drug 9:13 a.m. March 11, 2010 - Val Brickates Kennedy
Drug stocks slump; Sequenom jumps on upgrade 1:50 p.m. May 27, 2009 - Val Brickates Kennedy
Cytokinetics appoints Sabry executive chairman 4:27 p.m. Jan. 22, 2007 - Ruth Mantell
Cytokinetics names James Sabry as executive chairman 4:02 p.m. Jan. 22, 2007 - Katherine Hunt
Cytokinetics names Robert Blum as CEO 4:02 p.m. Jan. 22, 2007 - Katherine Hunt
Stem-cell rally as sector moves broadly higher 4:44 p.m. Jan. 4, 2007 - Val Brickates Kennedy
Wednesday's biggest U.S. stock gainers and decliners 5:55 p.m. Jan. 3, 2007 - MarketWatch
Drug stocks mixed; Cytokinetics soars on Amgen deal 4:40 p.m. Jan. 3, 2007 - Val Brickates Kennedy
Cytokinetics, Amgen ink deal to develop heart-failure drugs 11:33 a.m. Jan. 3, 2007 - Val Brickates Kennedy
Jim Cramer's 'Mad Money' Recap: You'll Make More Money Buying Into Panic 8:23 p.m. Jan. 8, 2015 - TheStreet.com
8 Biotechnology Stocks to Buy Now 2:45 a.m. Jan. 7, 2015 - InvestorPlace.com
Cytokinetics (CYTK) Is Weak On High Volume Today 10:09 a.m. Jan. 2, 2015 - TheStreet.com
Cytokinetics (CYTK) Looks Good: Stock Soars 16.1% - Tale of the Tape 9:25 a.m. Jan. 2, 2015 - Zacks.com
Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Clinical Study Update 1:17 p.m. Dec. 31, 2014 - benzinga.com
Cytokinetics (CYTK) Stock Rises Today After Roth Capital Increases Price Target 11:44 a.m. Dec. 31, 2014 - TheStreet.com
Mid-Day Gainers From New Year's Eve 2014: NephroGenex And Other Biopharma Stocks 11:42 a.m. Dec. 31, 2014 - benzinga.com
Cytokinetics Surges Amid Roth Capital Raising Its Price Target 10:52 a.m. Dec. 31, 2014 - benzinga.com
Kite Pharma Files IND for Non-Hodgkin Lymphoma Drug - Analyst Blog 5:20 p.m. Dec. 29, 2014 - Zacks.com
Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More 4:00 p.m. Dec. 26, 2014 - Seeking Alpha
Strong On High Volume: Cytokinetics (CYTK) 10:59 a.m. Dec. 26, 2014 - TheStreet.com
Will Cytokinetics (CYTK) Continue to Surge Higher? - Tale of the Tape 9:50 a.m. Dec. 26, 2014 - Zacks.com
Cytokinetics Rises After Extending Astellas Agreement - Analyst Blog 5:10 p.m. Dec. 24, 2014 - Zacks.com
Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog 2:10 p.m. Dec. 24, 2014 - Zacks.com
Cytokinetics, Incorporated (CYTK) Rises: Stock Jumps 12.6% - Tale of the Tape 9:32 a.m. Dec. 24, 2014 - Zacks.com
Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog 2:30 p.m. Dec. 23, 2014 - Zacks.com
Walgreens Beats Q1 Earnings, Alliance Boots Deal Bears Fruit - Analyst Blog 2:02 p.m. Dec. 23, 2014 - Zacks.com
Cytokinetics, Astellas Continue on Muscle Treatment 9:53 a.m. Dec. 23, 2014 - The Wall Street Journal Interactive Edition
Morning Market Movers 8:54 a.m. Dec. 23, 2014 - benzinga.com
Cytokinetics and Astellas expand partnership 8:28 a.m. Dec. 23, 2014 - Seeking Alpha
Happy New 'Investing' Year: Complementary Reports on Daily Journal, Trina Solar, Cytokinetics, BrainStorm, and Resolute 8:10 a.m. Jan. 2, 2015 - PR Newswire - PRF
Cytokinetics and Astellas Announce Expansion of Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Neuromuscular Indications 7:30 a.m. Dec. 23, 2014 - Thomson Reuters ONE
Cytokinetics Announces Presentations Relating to Tirasemtiv and Effects on Respiratory Muscle Function at International Symposium on ALS/MND 8:01 a.m. Dec. 5, 2014 - Thomson Reuters ONE
Cytokinetics Announces Presentations Relating to Tirasemtiv at the 25th International Symposium on ALS/MND 4:01 p.m. Dec. 1, 2014 - Thomson Reuters ONE
Cytokinetics to Participate in the 26th Annual Piper Jaffray Healthcare Conference 4:01 p.m. Nov. 26, 2014 - Thomson Reuters ONE
Critical Alerts For Outerwall, Cytokinetics, Union Pacific, Accenture and Monsanto Released By InvestorsObserver 9:31 a.m. Nov. 25, 2014 - PR Newswire - PRF
Cytokinetics' President & CEO Robert Blum Receives 2014 Lou Gehrig Iron Horse Award From ALS Therapy Development Institute 7:31 a.m. Nov. 10, 2014 - Thomson Reuters ONE
Cytokinetics, Incorporated Reports Third Quarter 2014 Financial Results 3:01 p.m. Oct. 30, 2014 - Thomson Reuters ONE
Cytokinetics Provides Development Program Update for Omecamtiv Mecarbil 6:31 a.m. Oct. 27, 2014 - Thomson Reuters ONE
Cytokinetics Provides Development Program Update for Tirasemtiv 6:31 a.m. Oct. 20, 2014 - Thomson Reuters ONE
Cytokinetics to Announce Third Quarter Results on October 30, 2014 4:35 p.m. Oct. 16, 2014 - Thomson Reuters ONE
Cytokinetics Announces Development Program Update for CK-2127107 6:31 a.m. Oct. 13, 2014 - Thomson Reuters ONE
Anacor Pharmaceuticals Appoints Wendell Wierenga to Its Board of Directors 7:30 a.m. Sept. 12, 2014 - BusinessWire - BZX
Cytokinetics to Present at the 34th Annual Canaccord Global Growth Conference 3:01 p.m. Aug. 7, 2014 - Thomson Reuters ONE
Cytokinetics, Incorporated Reports Second Quarter 2014 Financial Results 11:18 p.m. July 30, 2014 - Thomson Reuters ONE
Cytokinetics to Announce Second Quarter Results on July 30, 2014 1:46 a.m. July 17, 2014 - Thomson Reuters ONE
Cytokinetics Announced Additional Results Relating to Tirasemtiv from Pre-Specificed Subgroup Analyses of BENEFIT-ALS 6:31 a.m. July 10, 2014 - Thomson Reuters ONE
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 4:55 a.m. July 7, 2014 - PR Newswire - PRF
Cytokinetics Announces Additional Data from BENEFIT-ALS to be Presented at the 13th International Congress on Neuromuscular Diseases 6:32 a.m. July 3, 2014 - Thomson Reuters ONE
Cytokinetics Announces Data Relating to Tirasemtiv Presented at the 2014 Annual Spinal Muscular Atrophy Conference 3:01 p.m. June 13, 2014 - Thomson Reuters ONE
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
Cytokinetics plunges 60% after Lou Gehrig's disease drug fails test 9:26 a.m. April 25, 2014 - Russ Britt
Cytokinetics's massive stock plunge may be premature, analyst says 5:18 p.m. Sept. 3, 2013 - Russ Britt
Cytokinetics shares plummet after heart drug fails to meet primary goal 9:56 a.m. Sept. 3, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 6:57 a.m. Aug. 14, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:00 a.m. July 24, 2013 - Shawn Langlois
Cytokinetics rallies on study publication 11:31 a.m. Sept. 27, 2011 - Val Brickates Kennedy
Cytokinetics sinks 18% in early trading 10:37 a.m. Aug. 8, 2011 - Val Brickates Kennedy
Drug indexes hug the flat line 10:57 a.m. Dec. 13, 2010 - Val Brickates Kennedy
Drug indexes sluggish; Cytokinetics plunges 10:07 a.m. Dec. 13, 2010 - Val Brickates Kennedy
Cytokinetics shares up 5% 9:34 a.m. Dec. 7, 2010 - Nick Godt
Cytokinetics to begin Phase II testing of ALS drug 9:13 a.m. March 11, 2010 - Val Brickates Kennedy
Drug stocks slump; Sequenom jumps on upgrade 1:50 p.m. May 27, 2009 - Val Brickates Kennedy
Cytokinetics appoints Sabry executive chairman 4:27 p.m. Jan. 22, 2007 - Ruth Mantell
Cytokinetics names James Sabry as executive chairman 4:02 p.m. Jan. 22, 2007 - Katherine Hunt
Cytokinetics names Robert Blum as CEO 4:02 p.m. Jan. 22, 2007 - Katherine Hunt
Stem-cell rally as sector moves broadly higher 4:44 p.m. Jan. 4, 2007 - Val Brickates Kennedy
Wednesday's biggest U.S. stock gainers and decliners 5:55 p.m. Jan. 3, 2007 - MarketWatch
Drug stocks mixed; Cytokinetics soars on Amgen deal 4:40 p.m. Jan. 3, 2007 - Val Brickates Kennedy
Cytokinetics, Amgen ink deal to develop heart-failure drugs 11:33 a.m. Jan. 3, 2007 - Val Brickates Kennedy
Jim Cramer's 'Mad Money' Recap: You'll Make More Money Buying Into Panic 8:23 p.m. Jan. 8, 2015 - TheStreet.com
8 Biotechnology Stocks to Buy Now 2:45 a.m. Jan. 7, 2015 - InvestorPlace.com
Cytokinetics (CYTK) Is Weak On High Volume Today 10:09 a.m. Jan. 2, 2015 - TheStreet.com
Cytokinetics (CYTK) Looks Good: Stock Soars 16.1% - Tale of the Tape 9:25 a.m. Jan. 2, 2015 - Zacks.com
Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Clinical Study Update 1:17 p.m. Dec. 31, 2014 - benzinga.com
Cytokinetics (CYTK) Stock Rises Today After Roth Capital Increases Price Target 11:44 a.m. Dec. 31, 2014 - TheStreet.com
Mid-Day Gainers From New Year's Eve 2014: NephroGenex And Other Biopharma Stocks 11:42 a.m. Dec. 31, 2014 - benzinga.com
Cytokinetics Surges Amid Roth Capital Raising Its Price Target 10:52 a.m. Dec. 31, 2014 - benzinga.com
Kite Pharma Files IND for Non-Hodgkin Lymphoma Drug - Analyst Blog 5:20 p.m. Dec. 29, 2014 - Zacks.com
Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More 4:00 p.m. Dec. 26, 2014 - Seeking Alpha
Strong On High Volume: Cytokinetics (CYTK) 10:59 a.m. Dec. 26, 2014 - TheStreet.com
Will Cytokinetics (CYTK) Continue to Surge Higher? - Tale of the Tape 9:50 a.m. Dec. 26, 2014 - Zacks.com
Cytokinetics Rises After Extending Astellas Agreement - Analyst Blog 5:10 p.m. Dec. 24, 2014 - Zacks.com
Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog 2:10 p.m. Dec. 24, 2014 - Zacks.com
Cytokinetics, Incorporated (CYTK) Rises: Stock Jumps 12.6% - Tale of the Tape 9:32 a.m. Dec. 24, 2014 - Zacks.com
Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog 2:30 p.m. Dec. 23, 2014 - Zacks.com
Walgreens Beats Q1 Earnings, Alliance Boots Deal Bears Fruit - Analyst Blog 2:02 p.m. Dec. 23, 2014 - Zacks.com
Cytokinetics, Astellas Continue on Muscle Treatment 9:53 a.m. Dec. 23, 2014 - The Wall Street Journal Interactive Edition
Morning Market Movers 8:54 a.m. Dec. 23, 2014 - benzinga.com
Cytokinetics and Astellas expand partnership 8:28 a.m. Dec. 23, 2014 - Seeking Alpha
Happy New 'Investing' Year: Complementary Reports on Daily Journal, Trina Solar, Cytokinetics, BrainStorm, and Resolute 8:10 a.m. Jan. 2, 2015 - PR Newswire - PRF
Cytokinetics and Astellas Announce Expansion of Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Neuromuscular Indications 7:30 a.m. Dec. 23, 2014 - Thomson Reuters ONE
Cytokinetics Announces Presentations Relating to Tirasemtiv and Effects on Respiratory Muscle Function at International Symposium on ALS/MND 8:01 a.m. Dec. 5, 2014 - Thomson Reuters ONE
Cytokinetics Announces Presentations Relating to Tirasemtiv at the 25th International Symposium on ALS/MND 4:01 p.m. Dec. 1, 2014 - Thomson Reuters ONE
Cytokinetics to Participate in the 26th Annual Piper Jaffray Healthcare Conference 4:01 p.m. Nov. 26, 2014 - Thomson Reuters ONE
Critical Alerts For Outerwall, Cytokinetics, Union Pacific, Accenture and Monsanto Released By InvestorsObserver 9:31 a.m. Nov. 25, 2014 - PR Newswire - PRF
Cytokinetics' President & CEO Robert Blum Receives 2014 Lou Gehrig Iron Horse Award From ALS Therapy Development Institute 7:31 a.m. Nov. 10, 2014 - Thomson Reuters ONE
Cytokinetics, Incorporated Reports Third Quarter 2014 Financial Results 3:01 p.m. Oct. 30, 2014 - Thomson Reuters ONE
Cytokinetics Provides Development Program Update for Omecamtiv Mecarbil 6:31 a.m. Oct. 27, 2014 - Thomson Reuters ONE
Cytokinetics Provides Development Program Update for Tirasemtiv 6:31 a.m. Oct. 20, 2014 - Thomson Reuters ONE
Cytokinetics to Announce Third Quarter Results on October 30, 2014 4:35 p.m. Oct. 16, 2014 - Thomson Reuters ONE
Cytokinetics Announces Development Program Update for CK-2127107 6:31 a.m. Oct. 13, 2014 - Thomson Reuters ONE
Anacor Pharmaceuticals Appoints Wendell Wierenga to Its Board of Directors 7:30 a.m. Sept. 12, 2014 - BusinessWire - BZX
Cytokinetics to Present at the 34th Annual Canaccord Global Growth Conference 3:01 p.m. Aug. 7, 2014 - Thomson Reuters ONE
Cytokinetics, Incorporated Reports Second Quarter 2014 Financial Results 11:18 p.m. July 30, 2014 - Thomson Reuters ONE
Cytokinetics to Announce Second Quarter Results on July 30, 2014 1:46 a.m. July 17, 2014 - Thomson Reuters ONE
Cytokinetics Announced Additional Results Relating to Tirasemtiv from Pre-Specificed Subgroup Analyses of BENEFIT-ALS 6:31 a.m. July 10, 2014 - Thomson Reuters ONE
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 4:55 a.m. July 7, 2014 - PR Newswire - PRF
Cytokinetics Announces Additional Data from BENEFIT-ALS to be Presented at the 13th International Congress on Neuromuscular Diseases 6:32 a.m. July 3, 2014 - Thomson Reuters ONE
Cytokinetics Announces Data Relating to Tirasemtiv Presented at the 2014 Annual Spinal Muscular Atrophy Conference 3:01 p.m. June 13, 2014 - Thomson Reuters ONE
(0)
(0)Scroll down for more posts ▼